The miR-17-92 cluster and its target THBS1 are differentially expressed in angiosarcomas dependent on MYC amplification

Small RNA Sequencing and Functional Characterization Reveals MicroRNA-143 Tumor Suppressor Activity in Liposarcoma

(2011) S. Ugras et al.   CANCER RESEARCH

A transcriptome signature distinguished sporadic from postradiotherapy radiation-induced sarcomas

(2011) Nabila-Sandra Hadj-Hamou et al.   CARCINOGENESIS

Refining tumor-associated aneuploidy through ‘genomic recoding’ of recurrent DNA copy number aberrations in 150 canine non-Hodgkin lymphomas

(2011) Rachael Thomas et al.   LEUKEMIA & LYMPHOMA

A switch in Notch gene expression parallels stem cell to endothelial transition in infantile hemangioma

(2010) June K. Wu et al.   ANGIOGENESIS

The Myc-miR-17 92 Axis Blunts TGF  Signaling and Production of Multiple TGF -Dependent Antiangiogenic Factors

(2010) M. Dews et al.   CANCER RESEARCH

EWSR1-POU5F1 fusion in soft tissue myoepithelial tumors. A molecular analysis of sixty-six cases, including soft tissue, bone, and visceral lesions, showing common involvement of the EWSR1 gene

(2010) Cristina R. Antonescu et al.   GENES CHROMOSOMES & CANCER

Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions

(2010) Tianhua Guo et al.   GENES CHROMOSOMES & CANCER

Differential expression analysis for sequence count data

(2010) Simon Anders et al.   GENOME BIOLOGY

Identification of Signaling Systems in Proliferating and Involuting Phase Infantile Hemangiomas by Genome-Wide Transcriptional Profiling

(2009) Monica L. Calicchio et al.   AMERICAN JOURNAL OF PATHOLOGY

MYC High Level Gene Amplification Is a Distinctive Feature of Angiosarcomas after Irradiation or Chronic Lymphedema

(2009) Johanna Manner et al.   AMERICAN JOURNAL OF PATHOLOGY

Randomized, Phase II Study of the Thrombospondin-1-Mimetic Angiogenesis Inhibitor ABT-510 in Patients With Advanced Soft Tissue Sarcoma

(2008) Laurence H. Baker et al.   JOURNAL OF CLINICAL ONCOLOGY